Intestinal microbiota could also alter bile acid metabolism, contributing to the pathogenesis of NAFLD by modulating farnesoid X receptor (FXR) stimulation and thus affecting fat and glucose homeostasis [31]. The gene discussed is NR1H4; the disease is metabolic dysfunction-associated steatotic liver disease.